InPharm - Research and Development
Confirms cost-reduction plans as part of an 'operational excellence' initiative
This week's roundup of CRO news includes updates from Cyprotex, INC Research, Laxai Pharma and Epistem
Biotech's chief executive wants Sanofi to recognise his company’s strategic value
Boosts rare diseases portfolio with purchase of US drug discovery company FoldRx
Features
Dominic Tyer and Andrew McConaghie examine the phenomenon of the iPhone app, and consider its role in a potential revolution in healthcare
